Effect of Mat Pilates Training on Women After Menopause

Not Applicable

Completed

• Conditions: Physical Activity; Blood Pressure

• Registration Number: NCT03626792
• Lead Sponsor: Federal University of Uberlandia

Brief Summary

This project aims to verify the chronic effect of Mat Pilates exercise on climacteric symptoms, ambulatory blood pressure responses, lipid and glucose profile and pro and anti-inflammatory and antioxidant markers in postmenopausal normotensive and hypertensive women. All volunteers received the same intervention.

Detailed Description

The Pilates program was performed three times a week for 12 weeks. Initially a familiarization was made regarding the principles of the method. All volunteers underwent 24-hour blood pressure assessment using ambulatory blood pressure measurement (ABPM) and venous blood samples were collected from fasting, saliva and questionnaires before and after the Pilates training period.

Study Timeline

• Study First Submitted: 2017-04-24
• Study Start: 2017-08-05
• Primary Completion: 2017-12-20
• Study Completion: 2018-03-28
• Study First Submitted QC: 2018-08-09
• Study First Posted: 2018-08-13
• Status Verified: 2022-03
• Last Update Submitted: 2022-03-07
• Last Update Posted: 2022-03-22

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 50

Inclusion Criteria

• Women between the ages of 40 and 70;
• Be post menopausal (amenorrhea for at least 12 months);
• Medical release to perform physical activities.
• Do not present physical problems or cardiovascular complications that prevent the performance of physical exercises;

Exclusion Criteria

• To present a history of stroke or acute myocardial infarction;
• Smoking;
• Diagnosis of Diabetes Mellitus.
• Present renal pathologies.
• Use medications that interfere with lipid metabolism;
• Use of antihypertensive drugs (except for the hypertensive group);
• Use hormone replacement therapies;
• Present gastrointestinal conditions.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Blood pressure	Change from Baseline at 12 weeks	Resting diastolic and systolic blood pressures will be monitored by Microlife® BP 3BT0A automatic monitor in mmHg.

Secondary Outcome Measures

Name	Time	Method
Kupperman - Blatt Index	Change from Baseline at 12 weeks	The climacteric symptoms will be evaluated by the following questionnaire Kupperman - Blatt Index. The questionnaire has scores that from 0 to 19 indicate mild symptoms, 20 to 35 moderate and greater than 35 symptoms of severe climacteric.
Menopause Rating Scale (MRS)	Change from Baseline at 12 weeks	The climacteric symptoms will be evaluated by the following questionnaire Menopause Rating Scale (MRS). The scores from 0 to 4 of the questionnaire indicate absence of symptoms, as well as from 5 to 8 presence of mild symptoms, 9 to 15 moderate and greater than 16 symptoms of severe climacteric.
Cervical Scale	Change from Baseline at 12 weeks	The climacteric symptoms will be evaluated by the following questionnaire Cervical Scale. The questionnaire does not have scales. Indicates only a high or low score regarding the presence of climacteric symptoms.
Sleep quality	Change from Baseline at 12 weeks	Sleep quality will be assessed by the Pittsburgh Sleep Quality Index (PSQI).A score of 0 to 4 indicates a good quality of sleep, 5 to 10 quality of bad sleep and greater than 10 the presence of sleep disorder.
Ambulatory blood pressure monitoring	Change from Baseline at 12 weeks	Ambulatory blood pressure monitoring will be monitored during 24 hours using a Dyna+ ABPM device in mmHg.

Trial Locations

Locations (1)

Jaqueline Pontes Batista; 🇧🇷 Uberlândia, Minas Gerais, Brazil